• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM
Click for more information
0.00% 42.0¢

IMMUTEP LIMITED - Charts / Financials

Market Cap $499.3M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 02/05/2024 (20 minute delay) ?
Day
Open 42.0¢   Day High 43.0¢   Day Low 40.5¢
Daily Volume 2653859
Bids   Sellers
Number Price Volume   Number Price Volume
1 41.5¢ 24000   47 42.0¢ 101546

Directors & Senior Management

Mr. Marc Voigt Chief Executive Officer, Executive Director
Ms. Deanne Miller Chief Operating Officer, General Counsel, Joint Company Secretary
Dr. Frederic Triebel Chief Scientific Officer, Executive Director
Mr. Florian D. Vogl Chief Medical Officer
Ms. Indira Naidu Joint Company Secretary
Dr. Russell John Howard Independent Non-Executive Chairman of the Board
Mr. Peter A. Meyers Independent Non-Executive Deputy Chairman of the Board
Ms. Lis Boyce Non-Executive Director
Ms. Anne Anderson Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
42.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $499.3M
Open High Low Value Volume
42.0¢ 43.0¢ 40.5¢ $1.108M 2.653M

Buyers (Bids)

No. Vol. Price($)
1 24000 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 101546 47
View Market Depth
Last trade - 16.10pm 02/05/2024 (20 minute delay) ?
Last
42.0¢ 		  Change
0.000 ( 0.90 %)
Open High Low Volume
43.0¢ 43.0¢ 41.0¢ 749406
Last updated 15.59pm 02/05/2024 ?

Top Stories

Provident Aurum's off-market bid sends Sihayo shares soaring

Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
Carnarvon revs up for revised Dorado Development The Dorado discovery appears on again, with Carnarvon Energy announcing the JV completing a revision of the project’s design to optimise capital costs and accelerate FID by the end of 2024.
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Recharged Prospects: 'Watts' on the horizon for copper & lithium The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
Lithium Universe ends the quarter charged up for Quebec Refinery roll-out Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.